Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


26.09.2016

2 Ann Nucl Med
5 Clin Nucl Med
5 J Nucl Cardiol
2 Phys Med Biol
3 Semin Nucl Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Nucl Med

  1. YOO J, Yoon HJ, Kim BS
    Prognostic value of primary tumor SUVmax on F-18 FDG PET/CT compared with semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available

  2. CARRIO I, Kinuya S
    New section in EJNMMI and Annals of Nuclear Medicine.
    Ann Nucl Med. 2016.
    PubMed     Text format    


    Clin Nucl Med

  3. PAPADAKIS GZ, Millo C, Bagci U, Blau J, et al
    18F-NaF and 18F-FDG PET/CT in Gorham-Stout Disease.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  4. JIN X, Jing H, Liu Y, Li F, et al
    Familial Gigantiform Cementoma on 99mTc MDP Bone Scintigraphy.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  5. MAYERHOEFER ME, Karanikas G, Kletter K, Kiesewetter B, et al
    Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  6. VARDHANABHUTI V, Lo AW, Lee EY, Law SY, et al
    Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available

  7. BEPPU T, Terasaki K, Sasaki T, Sato Y, et al
    MRI and 11C-methyl-L-methionine PET Differentiate Bevacizumab True Responders After Initiating Therapy for Recurrent Glioblastoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    J Nucl Cardiol

  8. NENSA F, Kloth J, Tezgah E, Poeppel TD, et al
    Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    J Nucl Cardiol. 2016.
    PubMed     Text format     Abstract available

  9. GOULD KL
    Optimizing quantitative myocardial perfusion by positron emission tomography for guiding CAD management.
    J Nucl Cardiol. 2016.
    PubMed     Text format    

  10. PILEBRO B, Arvidsson S, Lindqvist P, Sundstrom T, et al
    Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
    J Nucl Cardiol. 2016.
    PubMed     Text format     Abstract available

  11. BOKHARI S, Morgenstern R, Weinberg R, Kinkhabwala M, et al
    Erratum to: Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.
    J Nucl Cardiol. 2016.
    PubMed     Text format    

  12. MASUDA A, Yamaki T, Kunii H, Nemoto A, et al
    Inflammatory involvement in a patient with Leriche syndrome evaluated by 18F-fluorodeoxyglucose PET/MRI.
    J Nucl Cardiol. 2016.
    PubMed     Text format    


    Phys Med Biol

  13. TASHIMA H, Yamaya T
    Proposed helmet PET geometries with add-on detectors for high sensitivity brain imaging.
    Phys Med Biol. 2016;61:7205-7220.
    PubMed     Text format     Abstract available

  14. SPANGLER-BICKELL MG, Zhou L, Kyme AZ, De Laat B, et al
    Optimising rigid motion compensation for small animal brain PET imaging.
    Phys Med Biol. 2016;61:7074-7091.
    PubMed     Text format     Abstract available


    Semin Nucl Med

  15. DI GIALLEONARDO V, Wilson DM, Keshari KR
    The Potential of Metabolic Imaging.
    Semin Nucl Med. 2016;46:28-39.
    PubMed     Text format     Abstract available

  16. OSBORNE JR
    Guest Editorial.
    Semin Nucl Med. 2016;46:3-4.
    PubMed     Text format    

  17. FREEMAN LM, Blaufox MD
    Letter from the Editors.
    Semin Nucl Med. 2016;46:1-2.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: